TrialThe Pediatric infectious disease journal2026

Safety and Pharmacokinetics of the RSV Fusion Inhibitor Sisunatovir Across Two Early-phase Studies in Infants and Children With RSV Lower Respiratory Tract Infection.

Sima S Toussi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.